Haemonetics Corporation (NYSE:HAE) is reporting fourth quarter earnings results on Tuesday 8th May 2018, before the bell.
The consensus estimates from Thomson Reuters are income of $ 0.42 per share from $ 227.12 million in revenue.
The same period from last year, HAE reportedly had income of $ 0.39 per share on $ 228.07 million in revenue.
For the full year, analysts predict revenues of $ 898.02 million, while looking forward to income of $ 1.87 per share.
About Haemonetics Corporation
|% Change from 52 Week Low|
|% Change from 52 Week High|